Prospects for Spin Physics at RHIC

Colliding beams of 70% polarized protons at up to $\sqrt{s}$=500 GeV, with high luminosity, L=2$\times10^{{\rm 32}}$ cm$^{-2}$sec$^{-1}$, will represent a new and unique laboratory for studying the proton. RHIC-Spin will be the first polarized-proton collider and will be capable of copious production of jets, directly produced photons, and $W$ and $Z$ bosons. Features will include direct and precise measurements of the polarization of the gluons and of $\bar{u}$, $\bar{d}$, $u$, and $d$ quarks in a polarized proton. Parity violation searches for physics beyond the standard model will be competitive with unpolarized searches at the Fermilab Tevatron. Transverse spin will explore transversity for the first time, as well as quark-gluon correlations in the proton. Spin dependence of the total cross section and in the Coulomb nuclear interference region will be measured at collider energies for the first time. These qualitatively new measurements can be expected to deepen our understanding of the structure of matter and of the strong interaction.Comment: 51 pages, 22 figures. Scheduled to appear in the Annual Review of Nuclear and Particle Science Vol. 50, to be published in December 2000 by Annual Reviews, http://AnnualReviews.or

Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART—a UK, multicentre, observational study

Abstract: Background: Although coronavirus disease 2019 (COVID-19) is primarily a respiratory illness, myocardial injury is increasingly reported and associated with adverse outcomes. However, the pathophysiology, extent of myocardial injury and clinical significance remains unclear. Methods: COVID-HEART is a UK, multicentre, prospective, observational, longitudinal cohort study of patients with confirmed COVID-19 and elevated troponin (sex-specific > 99th centile). Baseline assessment will be whilst recovering in-hospital or recently discharged, and include cardiovascular magnetic resonance (CMR) imaging, quality of life (QoL) assessments, electrocardiogram (ECG), serum biomarkers and genetics. Assessment at 6-months includes repeat CMR, QoL assessments and 6-min walk test (6MWT). The CMR protocol includes cine imaging, T1/T2 mapping, aortic distensibility, late gadolinium enhancement (LGE), and adenosine stress myocardial perfusion imaging in selected patients. The main objectives of the study are to: (1) characterise the extent and nature of myocardial involvement in COVID-19 patients with an elevated troponin, (2) assess how cardiac involvement and clinical outcome associate with recognised risk factors for mortality (age, sex, ethnicity and comorbidities) and genetic factors, (3) evaluate if differences in myocardial recovery at 6 months are dependent on demographics, genetics and comorbidities, (4) understand the impact of recovery status at 6 months on patient-reported QoL and functional capacity. Discussion: COVID-HEART will provide detailed characterisation of cardiac involvement, and its repair and recovery in relation to comorbidity, genetics, patient-reported QoL measures and functional capacity

Deuteron spin alignment in deuteron-proton scattering at 3.6 GEV/C : technical report

http://deepblue.lib.umich.edu/bitstream/2027.42/3945/5/bab8119.0001.001.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/3945/4/bab8119.0001.001.tx